Central Admixture Pharmacy Services (CAPS) has expanded its product portfolio, including two vasopressors: norepinephrine 8 mg added to 250 mL normal saline (NS), and vasopressin 50 units added to 50 mL NS. A third product added to the CAPS portfolio is midazolam 125 mg added to NS (1 mg/mL), a CSP used as a sedative. As hospital pharmacies have reported that these key drugs in a ready-to-use format are in short supply for ICU patients, CAPS is responding by adding crucial drugs to its portfolio of 503B compounded products.
CAPS (A B. Braun Company)
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.